Shelby Newsad is a Partner at Compound, focused on bio and health technologies. They previously worked as a bioscience researcher in plant sciences, neuroscience, and drug discovery.
At firms with a similar stage, sector and check size.
One email when Shelby's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckShelby Newsad is a Partner at Compound, focused on bio and health technologies. They previously worked as a bioscience researcher in plant sciences, neuroscience, and drug discovery.
Compound has not reported a check size. It invests at seed, series a.
Email [email protected], the firm's inbox for founders, and name Shelby in the subject. A warm intro from a founder Compound backed works better.
researcher at National Institutes of Health; researcher at Helmholtz Institute.
Last updated 2026-10-15. Is this you? Ask for a correction.